Platelet glycogenolysis is important for energy production and function

References

• Kanungo S, Wells K, Tribett T, El-Gharbawy A. Glycogen metabolism and glycogen storage disorders. Ann Transl Med. 2018;6(24):474. doi:10.21037/atm.2018.10.59.
   PubMed Web of Science ®Google Scholar
• Kramer PA, Ravi S, Chacko B, Johnson MS, Darley-Usmar VM. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol. 2014;2:206–10. doi:10.1016/j.redox.2013.12.026.
   PubMed Web of Science ®Google Scholar
• Aibibula M, Naseem KM, Sturmey RG. Glucose metabolism and metabolic flexibility in blood platelets. J Thromb Haemost. 2018;16(11):2300–14. doi:10.1111/jth.14274.
   PubMed Web of Science ®Google Scholar
• Scott RB, Cooper LW. Activation of glycogen phosphorylase in blood platelets. Blood. 1967;30(3):321–30. doi:10.1182/blood.V30.3.321.321.
   PubMed Web of Science ®Google Scholar
• Fidler TP, Campbell RA, Funari T, Dunne N, Balderas Angeles E, Middleton EA, Chaudhuri D, Weyrich AS, Abel ED. Deletion of GLUT1 and GLUT3 reveals multiple roles for glucose metabolism in platelet and megakaryocyte function. Cell Rep. 2017;20(4):881–94. doi:10.1016/j.celrep.2017.06.083.
   PubMed Web of Science ®Google Scholar
• Czapek EE, Deykin D, Salzman EW. Platelet dysfunction in glycogen storage disease type I. Blood. 1973;41(2):235–47. doi:10.1182/blood.V41.2.235.235.
   PubMed Web of Science ®Google Scholar
• Marti GE, Rick ME, Sidbury J, Gralnick HR. DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times. Blood. 1986;68(1):180–4. doi:10.1182/blood.V68.1.180.180.
   PubMed Web of Science ®Google Scholar
• Gilchrist GS, Fine RN, Donnell GN. The hemostatic defect in glycogen storage disease, type 1. Acta Paediatr Scand. 1968;57(3):205–8. doi:10.1111/j.1651-2227.1968.tb04679.x.
   PubMed Web of Science ®Google Scholar
• Austin SL, El-Gharbawy AH, Kasturi VG, James A, Kishnani PS. Menorrhagia in patients with type I glycogen storage disease. Obstet Gynecol. 2013;122(6):1246–54. doi:10.1097/01.AOG.0000435451.86108.82.
   PubMed Web of Science ®Google Scholar
• Mühlhausen C, Schneppenheim R, Budde U, Merkel M, Muschol N, Ullrich K, Santer R. Decreased plasma concentration of von Willebrand factor antigen (VWF:Ag) in patients with glycogen storage disease type Ia. J Inherit Metab Dis. 2005;28(6):945–50. doi:10.1007/s10545-005-0184-9.
   PubMed Web of Science ®Google Scholar
• Zois CE, Harris AL. Glycogen metabolism has a key role in the cancer microenvironment and provides new targets for cancer therapy. J Mol Med (Berl). 2016;94(2):137–54. doi:10.1007/s00109-015-1377-9.
   PubMed Web of Science ®Google Scholar
• Suh SW, Bergher JP, Anderson CM, Treadway JL, Fosgerau K, Swanson RA. Astrocyte glycogen sustains neuronal activity during hypoglycemia: studies with the glycogen phosphorylase inhibitor CP-316,819 ([R-R*,S*]-5-chloro-N-[2-hydroxy-3-(methoxymethylamino)-3-oxo-1-(phenylmethyl)propyl]-1H-indole-2-carboxamide). J Pharmacol Exp Ther. 2007;321(1):45–50. doi:10.1124/jpet.106.115550.
   PubMed Web of Science ®Google Scholar
• Baker DJ, Timmons JA, Greenhaff PL. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes. 2005;54(8):2453–9. doi:10.2337/diabetes.54.8.2453.
   PubMed Web of Science ®Google Scholar
• Floettmann E, Gregory L, Teague J, Myatt J, Hammond C, Poucher SM, Jones HB. Prolonged inhibition of glycogen phosphorylase in livers of Zucker diabetic fatty rats models human glycogen storage diseases. Toxicol Pathol. 2010;38(3):393–401. doi:10.1177/0192623310362707.
   PubMed Web of Science ®Google Scholar
• Prakhya KS, Luo Y, Adkins J, Hu X, Wang QJ, Whiteheart SW. A sensitive and adaptable method to measure platelet-fibrin clot contraction kinetics. Res Pract Thromb Haemost. 2022;6(5):e12755. doi:10.1002/rth2.12755.
   PubMed Web of Science ®Google Scholar
• Joshi S, Banerjee M, Zhang J, Kesaraju A, Pokrovskaya ID, Storrie B, Whiteheart SW. Alterations in platelet secretion differentially affect thrombosis and hemostasis. Blood Adv. 2018;2(17):2187–98. doi:10.1182/bloodadvances.2018019166.
   PubMed Web of Science ®Google Scholar
• Hubbard WB, Banerjee M, Vekaria H, Prakhya KS, Joshi S, Wang QJ, Saatman KE, Whiteheart SW, Sullivan PG. Differential leukocyte and platelet profiles in distinct models of traumatic brain injury. Cells. 2021;10(3):500. doi:10.3390/cells10030500.
   PubMed Web of Science ®Google Scholar
• George MJ, Bynum J, Nair P, Cap AP, Wade CE, Cox CS Jr, Gill BS. Platelet biomechanics, platelet bioenergetics, and applications to clinical practice and translational research. Platelets. 2018;29(5):431–9. doi:10.1080/09537104.2018.1453062.
   PubMed Web of Science ®Google Scholar
• Ravi S, Chacko B, Sawada H, Kramer PA, Johnson MS, Benavides GA, O’Donnell V, Marques MB, Darley-Usmar VM, Tan M. Metabolic plasticity in resting and thrombin activated platelets. PLos One. 2015;10(4):e0123597. doi:10.1371/journal.pone.0123597.
   PubMed Web of Science ®Google Scholar
• Sake CL, Metcalf AJ, Meagher M, Di Paola J, Neeves KB, Boyle NR. Isotopically nonstationary 13C metabolic flux analysis in resting and activated human platelets. Metab Eng. 2022;69:313–22. doi:10.1016/j.ymben.2021.12.007.
   PubMed Web of Science ®Google Scholar
• Detwiler TC, Zivkovic RV. Control of energy metabolism in platelets. A comparison of aerobic and anaerobic metabolism in washed rat platelets. Biochim Biophys Acta Bioenerg. 1970;197(2):117–26. doi:10.1016/0005-2728(70)90022-8.
   Google Scholar
• TeSlaa T, Bartman CR, Jankowski CSR, Zhang Z, Xu X, Xing X, Wang L, Lu W, Hui S, Rabinowitz JD. The source of glycolytic intermediates in mammalian tissues. Cell Metab. 2021;33(2):367–78.e5. doi:10.1016/j.cmet.2020.12.020.
   PubMed Web of Science ®Google Scholar
• Szymańska E, Jóźwiak-Dzięcielewska DA, Gronek J, Niewczas M, Czarny W, Rokicki D, Gronek P. Hepatic glycogen storage diseases: pathogenesis, clinical symptoms and therapeutic management. Arch Med Sci. 2019;17(2):304–13. doi:10.5114/aoms.2019.83063.
   PubMed Web of Science ®Google Scholar
• Bhattacharya K. Investigation and management of the hepatic glycogen storage diseases. Transl Pediatr. 2015;4(3):240–8. doi:10.3978/j.issn.2224-4336.2015.04.07.
   PubMed Web of Science ®Google Scholar